Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Adolescents (10-18 years) Adults (18+) Meningococcal disease
SAGE background document Rabies
Download:
Agenda & Minutes Germany Influenza Meningococcal disease Human papillomavirus (HPV)
Download:
Recommendation Belgium Meningococcal disease
Download:
Agenda & Minutes Australia Meningococcal disease
Download:
Evidence to recommendation table Rabies
Download:
Evidence to recommendation table Rabies
Download:
Recommendation United States of America Meningococcal disease
Download: